Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+

Summary

The biological response to treatment with tamoxifen in the preoperative situation is studying in this protocol. This study will enrolls patients with non-metastatic breast cancer HR +. The relationship between the CYP2D6 polymorphism, pharmacokinetics and biological efficacy of TAM will be studied.

Timeline

Start

2009-09

Primary completion

2016-10

Completion

2016-10

Drugs

Indications